Article: Nicotinamide Riboside Reduces Chemotherapy-Induced Eye and Body Hypersensitivity: Preclinical Findings

PrevNext
Neurological Health Neuropathy Preclinical Sensory (Auditory/Optical)

Nicotinamide Riboside Reduces Chemotherapy-Induced Eye and Body Hypersensitivity: Preclinical Findings

Synopsis

Chemotherapy often causes dry eye and nerve pain, which may be due to nerve damage. This study treated rats given the chemotherapy drug paclitaxel with nicotinamide riboside (NR). Paclitaxel caused eye sensitivity to touch and certain chemicals, increased tear production, and caused nerve pain in the hind paws. NR treatment reduced eye and paw sensitivity but did not affect tear production or nerve loss. These results suggest NR can relieve some chemotherapy-induced nerve pain without restoring lost nerve fibers, and this rat model may help study chemotherapy-related eye discomfort.

Journal

Investigative Ophthalmology & Visual Science

Share

Read more

Metabolic Health

Nicotinamide Riboside Rejuvenates Aged Hematopoietic Stem Cells and Improves Regeneration: Preclinical Findings

SynopsisWith age, hematopoietic stem cells (HSCs) lose their ability to regenerate and remain quiescent, leading to an expanded stem cell pool that can cause blood disorders. Researchers found that...

Read more
Cardiovascular Disease

Nicotinamide Riboside Reduces Heart Damage in Presence of Fentanyl, Midazolam, and Cangrelor: Preclinical Findings

SynopsisWhen blood flow to the heart is blocked and then restored—a process called ischemia-reperfusion injury—cells can be severely damaged. Researchers tested several potential protective compoun...

Read more